|
HOMER1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.719110E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.816100E-04 |
| Normal-vs-Stage2 |
1.397770E-02 |
| Normal-vs-Stage3 |
3.953700E-02 |
| Normal-vs-Stage4 |
6.276300E-03 |
| Stage1-vs-Stage2 |
2.907200E-01 |
| Stage1-vs-Stage3 |
1.078370E-01 |
| Stage1-vs-Stage4 |
5.875800E-01 |
| Stage2-vs-Stage3 |
6.038400E-01 |
| Stage2-vs-Stage4 |
8.231200E-01 |
| Stage3-vs-Stage4 |
4.034200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.335780E-03 |
| Normal-vs-AfricanAmerican |
2.658000E-03 |
| Normal-vs-Asian |
5.886200E-01 |
| Caucasian-vs-AfricanAmerican |
8.699200E-01 |
| Caucasian-vs-Asian |
4.653000E-01 |
| AfricanAmerican-vs-Asian |
4.849000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.791100E-04 |
| Normal-vs-Female |
3.670400E-02 |
| Male-vs-Female |
1.724400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.557200E-03 |
| Normal-vs-Extreme_Weight |
2.980100E-04 |
| Normal-vs-Obese |
3.100800E-03 |
| Normal-vs-Extreme_Obese |
1.092040E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.829650E-01 |
| Normal_Weight-vs-Obese |
9.042800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.043600E-01 |
| Extreme_Weight-vs-Obese |
7.137300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.707390E-01 |
| Obese-vs-Extreme_Obese |
9.599200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.784200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.077800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.195150E-03 |
| Normal-vs-Age(81-100Yrs) |
7.959400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.716400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.579800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.745000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.559800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.508800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.296600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.002800E-04 |
| Normal-VS-Type2 PRCC |
1.505640E-02 |
| Normal-VS-KIRP CIMP |
8.212500E-02 |
| Normal-VS-Unclassified PRCC |
3.895900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.271700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.238500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.665900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.464600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.643800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.056200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.263900E-03 |
| Normal-vs-N1 |
4.138600E-03 |
| Normal-vs-N2 |
1.910840E-01 |
| N0-vs-N1 |
5.883200E-01 |
| N0-vs-N2 |
8.660800E-01 |
| N1-vs-N2 |
5.508600E-01 |
|
|
